Organogenesis Holdings Inc. (NASDAQ:ORGO) Long Term Investor Notice: Investigation of Potential Wrongdoing

An investigation on behalf of current long term investors in Organogenesis Holdings Inc. (NASDAQ:ORGO) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

San Diego, CA — (SBWIRE) — 04/22/2022 — An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Organogenesis Holdings Inc.

Investors who are current long term investors in Organogenesis Holdings Inc. (NASDAQ: ORGO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm for current long term investors in NASDAQ: ORGO stocks follows a lawsuit filed against Organogenesis Holdings Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ORGO stocks, concerns whether certain Organogenesis Holdings Inc. directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products, that the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements, that as a result of all the foregoing, the Company’s revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/organogenesis-holdings-inc-nasdaqorgo-long-term-investor-notice-investigation-of-potential-wrongdoing-1356529.htm

Media Relations Contact

Christopher Clausen
Shareholders Foundation
Telephone: 1-858-779-1554
Email: Click to Email Christopher Clausen
Web: https://www.shareholdersfoundation.com/